668
Views
28
CrossRef citations to date
0
Altmetric
Articles

The INCATM (Inhaler Compliance AssessmentTM): A comparison with established measures of adherenceFootnote

, , , , , , , ORCID Icon & show all
Pages 1266-1287 | Received 30 Aug 2016, Accepted 30 Jan 2017, Published online: 28 Feb 2017

References

  • Berg, K. M., & Arnsten, J. H. (2006). Practical and conceptual challenges in measuring antiretroviral adherence. Journal of Acquired Immune Deficiency Syndromes, 43, S79–S87. doi:10.1097/01.qai.0000248337.97814.66
  • Blackstock, F. C., ZuWallack, R., Nici, L., & Lareau, S. C. (2016). Why don’t our patients with chronic obstructive pulmonary disease listen to us? The enigma of nonadherence. Annals of the American Thoracic Society, 13, 317–323. doi:10.1513/AnnalsATS.201509-600PS
  • Bonini, M., & Usmani, O. S. (2015). The importance of inhaler devices in the treatment of COPD. COPD Research and Practice, 1, 1–9. doi: 10.1186/s40749-015-0011-0
  • Bourbeau, J., & Bartlett, S. J. (2008). Patient adherence in COPD. Thorax, 63, 831–838. doi:10.1136/thx.2007.086041
  • Bryant, J., McDonald, V. M., Boyes, A., Sanson-Fisher, R., Paul, C., & Melville, J. (2013). Improving medication adherence in chronic obstructive pulmonary disease: A systematic review. Respiratory Research, 14(109), 1–8. doi:10.1186/1465-9921-14-109
  • Chan, A. H., Harrison, J., Black, P. N., Mitchell, E. A., & Foster, J. M. (2015). Using electronic monitoring devices to measure inhaler adherence: A practical guide for clinicians. The Journal of Allergy and Clinical Immunology: In Practice, 3, 335–349, e331–335. doi: 10.1016/j.jaip.2015.01.024
  • Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40, 373–383.10.1016/0021-9681(87)90171-8
  • Cramer, J. A., Roy, A., Burrell, A., Fairchild, C. J., Fuldeore, M. J., Ollendorf, D. A., & Wong, P. K. (2008). Medication compliance and persistence: Terminology and definitions. Value in Health, 11, 44–47. doi:10.1111/j.1524-4733.2007.00213.x
  • D’Arcy, S., MacHale, E., Seheult, J., Holmes, M. S., Hughes, C., Sulaiman, I., & Hyland, D. (2014). A method to assess adherence in inhaler use through analysis of acoustic recordings of inhaler events. PLoS ONE, 9, e98701. doi:10.1371/journal.pone.0098701
  • Di Martino, M., Agabiti, N., Bauleo, L., Kirchmayer, U., Cascini, S., Pistelli, R., & Colamesta, V. (2014). Use patterns of long-acting bronchodilators in routine COPD care: The OUTPUL study. COPD: Journal of Chronic Obstructive Pulmonary Disease, 11, 414–423. doi:10.3109/15412555.2013.839646
  • DiMatteo, M. R., Haskard-Zolnierek, K. B., & Martin, L. R. (2012). Improving patient adherence: A three-factor model to guide practice. Health Psychology Review, 6, 74–91. doi:10.1080/17437199.2010.537592
  • Fishman, P. A., Goodman, M. J., Hornbrook, M. C., Meenan, R. T., Bachman, D. J., & O’Keeffe Rosetti, M. C. (2003). Risk adjustment using automated ambulatory pharmacy data: The RxRisk model. Medical Care, 41, 84–99. doi:10.1097/01.mlr.0000039830.19812.29
  • Fletcher, C. M., Elmes, P. C., Fairbairn, A. S., & Wood, C. H. (1959). The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. British Medical Journal, 2, 257–266.10.1136/bmj.2.5147.257
  • Golay, A. (2011). Pharmacoeconomic aspects of poor adherence: Can better adherence reduce healthcare costs? Journal of Medical Economics, 14, 594–608. doi:10.3111/13696998.2011.597808
  • Hays, R. D., Anderson, R. T., & Revicki, D. (1998). Assessing reliability and validity of measurement in clinical trials. In M. J. Staquet, R. D. Hays, & P. Fayers. (Ed.), Quality of life assessment in clinical trials: Methods and Practice (pp. 169–182). New York: Oxford University Press.
  • Holmes, M. S., D’Arcy, S., Costello, R. W., & Reilly, R. B. (2014). Acoustic analysis of inhaler sounds from community-dwelling asthmatic patients for automatic assessment of adherence. IEEE Journal of Translational Engineering in Health and Medicine, 2, 2700210. doi:10.1109/jtehm.2014.2310480
  • Holmes, M. S., Seheult, J. N., Geraghty, C., D’Arcy, S., O’Brien, U., Crispino O’Connell, G., & Costello, R. B. (2013). A method of estimating inspiratory flow rate and volume from an inhaler using acoustic measurements. Physiological Measurement, 34, 903–914. doi:10.1088/0967-3334/34/8/903
  • Irish Thoracic Society. (2013). Lung disease in Ireland – Prevalence and trends: Implications for work force planning Retrieved 26 July 2016, from http://www.irishthoracicsociety.com/images/uploads/Lung%20Disease%20in%20Ireland%20December%202013.pdf
  • Jones, P. W., Harding, G., Berry, P., Wiklund, I., Chen, W. H., & Kline Leidy, N. (2009). Development and first validation of the COPD assessment test. European Respiratory Journal, 34, 648–654. doi:10.1183/09031936.00102509
  • Karve, S., Cleves, M. A., Helm, M., Hudson, T. J., West, D. S., & Martin, B. C. (2009). Good and poor adherence: Optimal cut-point for adherence measures using administrative claims data. Current Medical Research and Opinion, 25, 2303–2310. doi:10.1185/03007990903126833
  • Krousel-Wood, M., Islam, T., Webber, L. S., Re, R., Morisky, D. E., & Muntner, P. (2009). New medication adherence scale versus pharmacy fill rates in hypertensive seniors. The American Journal of Managed Care, 15(1), 59–66.
  • Lam, W. Y., & Fresco, P. (2015). Medication Adherence measures: An overview. BioMed Research International, 2015, 217047. doi:10.1155/2015/217047
  • Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. L. (2006). Global burden of disease and risk factors. Washington, DC: The World Bank.10.1596/978-0-8213-6262-4
  • Mac Hale, E., & Cowman, S. (2012). Inhaler Proficiency Schedule (IPS). MSc (Unpublished). Royal College of Surgeons in Ireland. Dublin.
  • Mewes, R., Rief, W., Kenn, K., Ried, J., & Stenzel, N. (2016). Psychological predictors for health-related quality of life and disability in persons with chronic obstructive pulmonary disease (COPD). Psychology & Health, 31, 470–486. doi:10.1080/08870446.2015.1111369
  • Michie, S., Richardson, M., Johnston, M., Abraham, C., Francis, J., Hardeman, W., & Eccles, M. P. (2013). The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: Building an international consensus for the reporting of behavior change interventions. Annals of Behavioral Medicine, 46, 81–95. doi:10.1007/s12160-013-9486-6
  • Morisky, D. E., Ang, A., Krousel-Wood, M., & Ward, H. J. (2008). Predictive validity of a medication adherence measure in an outpatient setting. The Journal of Clinical Hypertension, 10, 348–354.10.1111/j.1751-7176.2008.07572.x
  • Morisky, D. E. & DiMatteo, M. R. (2011). Improving the measurement of self-reported medication nonadherence: Response to Authors. Journal of Clinical Epidemiology, 64(3), 255–263. doi:10.1016/j.jclinepi.2010.09.002.
  • Nannini, L. J., Cates, C. J., Lasserson, T. J., & Poole, P. (2007). Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease. Cochrane Database Systemic Review (4), Cd006829. doi: 10.1002/14651858.cd006829
  • Nasreddine, Z. S., Phillips, N. A., Bedirian, V., Charbonneau, S., Whitehead, V., Collin, I., & Cummings, J.L. (2005). The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53, 695–699. doi:10.1111/j.1532-5415.2005.53221.x
  • Nishimura, K., Izumi, T., Tsukino, M., & Oga, T. (2002). Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest, 121, 1434–1440.10.1378/chest.121.5.1434
  • O’Caoimh, R., Timmons, S., & Molloy, D. W. (2016). Screening for Mild Cognitive Impairment: Comparison of “MCI Specific” screening instruments. Journal of Alzheimer's Disease, 51, 619–629. doi:10.3233/jad-150881
  • Phillips, L. A., Cohen, J., Burns, E., Abrams, J., & Renninger, S. (2016). Self-management of chronic illness: The role of ‘habit’ versus reflective factors in exercise and medication adherence. Journal of Behavioral Medicine, 39, 1076–1091. doi:10.1007/s10865-016-9732-z
  • Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., & Fukuchi, Y. (2007). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine, 176, 532–555. doi:10.1164/rccm.200703-456SO
  • Sattler, E. L., Lee, J. S., & Perri, M., 3rd. (2013). Medication (re)fill adherence measures derived from pharmacy claims data in older Americans: A review of the literature. Drugs and Aging, 30, 383–399. doi:10.1007/s40266-013-0074-z
  • Seheult, J. N., Costello, S., Tee, K. C., Bholah, T., Al Bannai, H., Sulaiman, I., & Costello, R. W. (2014). Investigating the relationship between peak inspiratory flow rate and volume of inhalation from a Diskus Inhaler and baseline spirometric parameters: A cross-sectional study. SpringerPlus, 3(496), 1–11. doi:10.1186/2193-1801-3-496
  • Seheult, J. N., O’Connell, P., Tee, K. C., Bholah, T., Al Bannai, H., Sulaiman, I., & MacHale, E. (2014). The acoustic features of inhalation can be used to quantify aerosol delivery from a Diskus dry powder inhaler. Pharmaceutical Research, 31, 2735–2747. doi:10.1007/s11095-014-1371-x
  • StataCorp. (2007). Stata statistical software: Release 10. College Station, TX: StataCorp LP.
  • Sulaiman, I., Cushen, B., Greene, G., Seheult, J., Seow, D., Rawat, F., & Costello, R. W. (2016). Objective assessment of adherence to inhalers by COPD patients. American Journal of Respiratory and Critical Care Medicine. doi:10.1164/rccm.201604-0733OC
  • Sutton, S., Kinmonth, A. L., Hardeman, W., Hughes, D., Boase, S., Prevost, A. T., & Kellar, I. (2014). Does electronic monitoring influence adherence to medication? Randomized controlled trial of measurement reactivity. Annals of Behavioral Medicine, 48, 293–299. doi:10.1007/s12160-014-9595-x
  • The Montreal Cognitive Assessment. (2009) Retrieved 20 June 2016, from http://www.mocatest.org/faq/
  • van Boven, J. F., Chavannes, N. H., van der Molen, T., Rutten-van Mölken, M. P., Postma, M. J., & Vegter, S. (2014). Clinical and economic impact of non-adherence in COPD: A systematic review. Respiratory Medicine, 108, 103–113. doi:10.1016/j.rmed.2013.08.044
  • van Dulmen, S., Sluijs, E., van Dijk, L., de Ridder, D., Heerdink, R., & Bensing, J. (2007). Patient adherence to medical treatment: A review of reviews. BMC Health Services Research, 7(542), 1–25. doi:10.1186/1472-6963-7-55
  • Vestbo, J., Anderson, J. A., Calverley, P. M., Celli, B., Ferguson, G. T., Jenkins, C., & Knobil, K. (2009). Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax, 64, 939–943. doi:10.1136/thx.2009.113662
  • WHO. (2003). Adherence to long-term therapies. Geneva: World Health Organization.
  • Williams, A. B., Amico, K. R., Bova, C., & Womack, J. A. (2013). A proposal for quality standards for measuring medication adherence in research. AIDS and Behavior, 17, 284–297. doi:10.1007/s10461-012-0172-7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.